Login to Your Account

Echoes of MediciNova

Nabi/Biota Structure Fuses Merger, Liquidation Benefits

By Trista Morrison

Monday, April 30, 2012

When Nabi Biopharmaceuticals Inc. revealed its plans to serve as a public shell for a reverse merger with Aussie biotech Biota Holdings Ltd., Raafat Fahim knew he'd face some opposition from shareholders.

To continue reading subscribe now to BioWorld Insight

Learn More about BioWorld Insight

Already a subscriber? Sign In or Buy now to activate your subscription